T.Man Pharmaceutical PCL (BKK:TMAN)

Thailand flag Thailand · Delayed Price · Currency is THB
11.90
-0.10 (-0.83%)
At close: Aug 15, 2025, 4:30 PM ICT
-0.83%
Market Cap4.76B
Revenue (ttm)2.25B
Net Income (ttm)440.99M
Shares Out400.00M
EPS (ttm)1.16
PE Ratio10.23
Forward PE9.71
Dividend0.20 (1.68%)
Ex-Dividend DateAug 26, 2025
Volume109,123
Average Volume277,703
Open12.00
Previous Close12.00
Day's Range11.90 - 12.10
52-Week Range9.90 - 19.30
Betan/a
RSI46.71
Earnings DateAug 13, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ... [Read more]

Sector Healthcare
Founded 1991
Employees 944
Stock Exchange Stock Exchange of Thailand
Ticker Symbol TMAN
Full Company Profile

Financial Performance

In 2024, T.Man Pharmaceutical PCL's revenue was 2.23 billion, an increase of 12.42% compared to the previous year's 1.98 billion. Earnings were 450.70 million, an increase of 4.55%.

Financial Statements

News

There is no news available yet.